FDA
-
-
-
-
-
-
-
Conatus Pharmaceuticals (CNAT) Reports Publication of Expanded Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
-
-
-
-
-
-
-
After-Hours Stock Movers 10/18: (LLNW) (ADBE) (GILD) Higher; (OPTT) (ESTE) (EBAY) Lower (more...)
-
-
-
-
-
-
-
Pre-Open Movers 05/11: (SGMO) (SYMX) (PEGA) Higher; (NH) (SNAP) (MNKD) Lower (more...)
-
-
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

